N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143171 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O3S |
| Mol.Wt. | 378.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143172 |
| CAS No | NA |
| Mol.F. | C7H5N3OS |
| Mol.Wt. | 179.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143173 |
| CAS No | NA |
| Mol.F. | C16H16N4O3 |
| Mol.Wt. | 312.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143174 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143175 |
| CAS No | NA |
| Mol.F. | C16H13N4O5 |
| Mol.Wt. | 341.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143176 |
| CAS No | NA |
| Mol.F. | C15H14N4OS |
| Mol.Wt. | 298.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143177 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143178 |
| CAS No | NA |
| Mol.F. | C18H18N4O6S |
| Mol.Wt. | 418.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143179 |
| CAS No | NA |
| Mol.F. | C16H16N4O4S |
| Mol.Wt. | 360.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143180 |
| CAS No | NA |
| Mol.F. | C26H26N6O5S2 |
| Mol.Wt. | 566.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143181 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.10 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143182 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143183 |
| CAS No | NA |
| Mol.F. | C12H11BrN2O2 |
| Mol.Wt. | 295.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143184 |
| CAS No | NA |
| Mol.F. | C12H10N2O2 |
| Mol.Wt. | 214.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143185 |
| CAS No | NA |
| Mol.F. | C17H14N4O3 |
| Mol.Wt. | 322.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143186 |
| CAS No | NA |
| Mol.F. | C13H18N4O3S |
| Mol.Wt. | 310.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |